AdvaMed® Statement on Dr. Jeff Shuren’s Retirement
Today, AdvaMed® President and CEO Scott Whitaker released the following statement about U.S. Food and Drug Administration Center for Devices and Radiological Health Director, Dr. Jeff Shuren.
Press Releases
Your source for the latest medtech news from AdvaMed® and our members.
Filter By:
Mary M. McLoughlin, Former MedTech Executive, Recruited as Strategic Advisor to MedTechVets
MedTechVets, a leading non-profit organization dedicated to supporting military veterans in transitioning into careers in the medical technology sector, proudly announces Mary McLoughlin will be consulting as Strategic Advisor effective…
Neuspera Medical Raises $23 Million in Series D Financing
Neuspera Medical, Inc., a neuromodulation company pioneering the Neuspera Implantable Sacral Neuromodulation (SNM) System, announced the closing of its Series D funding round raising $23 million and led by Vertex…
AdvaMed® Praises CMS Draft Rule Improving Patient Access to Alzheimer’s, Cancer Diagnostics
Today, the Centers for Medicare and Medicaid Services (CMS) issued the Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System proposed rule for CY25, which includes significant wins…
Press Contact
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
Wisconsin Biohealth Tech Hub Secures Phase 2 Award, Catalyzing Innovation and Economic Growth
The Wisconsin Biohealth Tech Hub, led by BioForward Wisconsin, achieves a significant milestone as a Phase 2 recipient of the U.S. Department of Commerce’s Economic Development Administration (EDA) Regional Technology…
Medtech POV with Scott Whitaker | Steve Mapa, Gulf War Veteran and Executive Director of MedTechVets on Supporting Veterans in the Medtech Industry
In the newest episode of Medtech POV, Steve Mapa, President and Executive Director of MedTechVets, joins host Scott Whitaker to talk about his career in the United States Army and…
House Committee Advances Bipartisan Bill to Expedite CMS Coverage of Breakthrough Medtech
The House Ways and Means Committee voted to pass the bipartisan H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act, during a markup meeting.
UroMems Raises Record $47 million (€44 Million) in Series C Financing to Fund Pivotal Clincial Trials of the UroActive™ System, the First Smart Automated Implant to Treat Stress Urinary Incontinence
UroMems, a global company developing innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI), today announced it has raised $47 million in its Series C financing, the largest fundraising…
Listen to AdvaMed®'s Podcast
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
AdvaMed® Signs New MOU with British Medtech Association
AdvaMed, The Medtech Association®, signed a renewed memorandum of understanding with the Association of British HealthTech Industries (ABHI) to strengthen the relationship between two of the leading medtech organizations in…